2023
DOI: 10.1158/1078-0432.22442187.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity

Abstract: <p>Supplementary Figures S1-S6; Supplementary Data; Supplementary Tables S1-S3.</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles